Skip to content

Stanford heart doctors bank on digital health to improve heart care in the future by monitoring encouraging exercise, detecting and tracking conditions like atrial fibrillation, and more.

Stanford heart doctors bank on digital health to improve heart care in the future by monitoring encouraging exercise, detecting and tracking conditions like atrial fibrillation, and more.

In this video, Stanford Medicine heart surgeon Joseph Woo discusses his award-winning research that examined the pros of cons of mechanical versus biological valve replacements.

In this video, Stanford Medicine heart surgeon Joseph Woo discusses his award-winning research that examined the pros of cons of mechanical versus biological valve replacements.

Published on

Ben Thornton received a heart transplant when he was 3-years-old and later suffered a complication that left him struggling to walk. Now, he's thriving as a wheelchair basketball player.

Ben Thornton received a heart transplant when he was 3-years-old and later suffered a complication that left him struggling to walk. Now, he's thriving as a wheelchair basketball player.

Published on

Rheumatoid arthritis and coronary artery disease share a common culprit: an important type of immune cell, called a macrophage, that has gone haywire. Stanford investigators have zeroed in on a molecular defect in macrophages' metabolic process that drives both disorders.

Rheumatoid arthritis and coronary artery disease share a common culprit: an important type of immune cell, called a macrophage, that has gone haywire. Stanford investigators have zeroed in on a molecular defect in macrophages' metabolic process that drives both disorders.

A minimally-invasive procedure called TAVR "gave me back my life in an immediate and profound way," said Stanford high-risk heart patient Laura Hosking.

A minimally-invasive procedure called TAVR "gave me back my life in an immediate and profound way," said Stanford high-risk heart patient Laura Hosking.

A conversation about a molecule called Ino80 led to findings that could help researchers develop therapies for a rare genetic disease of the heart muscle.

A conversation about a molecule called Ino80 led to findings that could help researchers develop therapies for a rare genetic disease of the heart muscle.